Advanced Search
WANG Yuxiang, TIAN Dandan, QIU Rong, TIAN Xiuming, WANG Lili. Influence Factors for Radiation Pneumonitis in Stage Ⅲ Non-small Cell Lung Cancer Patients Treated with Three-dimensional Conformal Radiotherapy[J]. Cancer Research on Prevention and Treatment, 2014, 41(12): 1307-1312. DOI: 10.3971/j.issn.1000-8578.2014.12.012
Citation: WANG Yuxiang, TIAN Dandan, QIU Rong, TIAN Xiuming, WANG Lili. Influence Factors for Radiation Pneumonitis in Stage Ⅲ Non-small Cell Lung Cancer Patients Treated with Three-dimensional Conformal Radiotherapy[J]. Cancer Research on Prevention and Treatment, 2014, 41(12): 1307-1312. DOI: 10.3971/j.issn.1000-8578.2014.12.012

Influence Factors for Radiation Pneumonitis in Stage Ⅲ Non-small Cell Lung Cancer Patients Treated with Three-dimensional Conformal Radiotherapy

More Information
  • Received Date: November 12, 2013
  • Revised Date: June 30, 2014
  • Objective To retrospectively analyze physical parameters and clinical factors for radiation pneumonitis(RP) in stage Ⅲ non-small cell lung cancer(NSCLC) patients treated with three-dimensional conformal radiotherapy(3D-CRT). Methods From January 2001 to December 2008, 203 NSCLC patients were treated with radical 3D-CRT, 163 males and 40 females; Median ages was 63-year-old(30~83); 21 patients were suffered from chronic obstructive pulmonary disease(COPD) medical history; 79 cases were in ⅢA stage and 124 cases were in ⅢB stage; 70 cases were treated with single radiotherapy and 133 cases with chemoradiotherapy, and median equivalent dose was 6 200 cGy (5 000-7 800 cGy). RP was evaluated with RTOG standard, and physical parameters of DVH was used to estimated RP grade≥2 and RP grade≥ 3. SPSS 13.0 software was used for statistic analysis. Results After 3DCRT, the rates of RP grade≥2 and grade≥3 were 32%(65/203) and 20.7%(42/203). Spearman correlation and single factor Logistic analysis showed that the mean lung dose, V5-V40 of total lung, COPD history, fractional radiation style, radiotherapy dose, GTV and GTV/volume of total lung were correlated with RP grade≥2 and grade≥3 (P<0.05); Logistic multivariate analysis revealed that V25 was the independent risk factor for RP grade ≥2 and grade ≥3. The optimal cutoff value for lung V25 was 29% in the receiver-operating characteristic (ROC) curve. COPD was the independent risk factor for RP grade ≥2. Conclusion DVH parameters were associated with the occurrence of RP. V25 might be the most effectively independent risk factor for RP grade≥2 and grade ≥3. COPD was the independent risk factor for RP grade≥2 in patients with non-small cell lung cancer.
  • [1]
    Rodrigues G, Lock M, D’Souza D, et al. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer- -a systematic review[J]. Radiother Oncol, 2004, 71(2):127-38.
    [2]
    Kim M, LeeJ, Ha B, et al. Factors predicting radiation pneumonitis in locally advanced non-small cell lung cancer[J]. Radiat Oncol J, 20 11, 29(3): 181-90.
    [3]
    Palma DA, Senan S, Tsujino K, et al. Predicting radiation pneumo nitis after chemoradiation therapy for lung cancer: an international individual patient data Meta-analysis[J]. Int J Radiat Oncol Biol Phys, 2013, 85(2): 444-50.
    [4]
    Fay M, Tan A, Fisher R, et al. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2005, 61 (5): 1355-63.
    [5]
    Fu HY, Lu B,Xu BQ, et al. Prospective study of lung V5 and V10 in predicting radiation-induced lung injury in advanced nonsmall- cell lung cancer treated with three-dimensional conformal radiation therapy[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 20 09, 18(6): 439-42. [付和谊, 卢冰, 徐冰清, 等. Ⅲ+Ⅳ期非小细 胞肺癌三维适形放疗正常肺V5、V10预测放射性肺损伤前瞻 性临床研究[J]. 中华放射肿瘤学杂志, 2009, 18(6): 439-42.]
    [6]
    Wang J, Qiao XY, Cao YK, et al. Analysis of correlated factors of radiation pneumonitis after three-dimensional conformal radiotherapy for non-small cell lung cancer[J].Zhongguo Zhong Liu Lin Chuang, 2009, 36(19): 1086-9. [王静, 乔学英, 曹彦坤, 等. 非小细胞肺癌三维适形放疗放射性肺炎发生的多因素分析 [J] 中国肿瘤临床, 2009, 36(19): 1086-9.]
    [7]
    Zhuang TT, Liu Q, Zhang L, et al. Risk factors of acute radiation pneumonitis in patients with non-small cell lung cancer after concurrent three-dimensional conformal radiotherapy and chemotherapy [J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 20 09, 18(6): 443-7. [庄婷婷, 柳青, 张黎, 等. 非小细胞肺癌三维 适形放疗同期化疗后急性放射性肺炎发生因素分析[J].中华放 射肿瘤学杂志, 2009, 18(6): 443-7.]
    [8]
    Zhu XZ, Wang LH, Wang YJ, et al. Risk factors of radiation pneumonitis in stage III non-small cell lung cancer treated with three-dimensional conformal radiotherapy[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 2007, 16(6): 421-8. [朱向帜, 王绿化, 王 颖杰, 等. 三维适形放疗局部晚期非小细胞肺癌的放射性肺炎 风险因素研究[J]. 中华放射肿瘤学杂志, 2007, 16(6): 421-8.]
    [9]
    Wang DQ, Zhang J, Li BS, et al. Dose-volume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve[J]. Zhonghua Fang She Yi Xue Yu Fang Hu Za Zhi, 2012, 32(5): 505-8. [王冬青, 张建, 李宝生, 等. 剂量体积直方图参数对放射性肺炎的工作特征曲线预测分析 [J] 中华放射医学与防护杂志, 2012, 32(5): 505-8.]
    [10]
    Yom SS, Liao Z, Liu HH, et al. Initial evaluation of treatmentrelated pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy[J]. Int J Radiat Oncol Biol Phys, 20 07, 68(1): 94-102.
    [11]
    Shi A, Zhu G, Wu H, et al. Analysis of clinical and dosimetric factors associated with severe acute radiationpneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy[J]. Radiat Oncol, 2010, 5: 35.
    [12]
    Oh D, Ahn YC, Park HC, et al. Prediction of radiation pneumonitis following high-dose thoracic radiation therapy by 3 Gy/fraction for non-small cell lung cancer: analysis of clinical and dosimetric factors[J]. Jpn J Clin Oncol, 2009, 39(3): 151-7.
    [13]
    Jin H, Tucker SL, Liu HH, et al. Dose-volume thresholds and smoking status for the risk of treatment-relatedpneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy [J]. Radiother Oncol, 2009, 91(3): 427-32.
    [14]
    Wang S, Liao Z, Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment-relatedpneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)[J]. Int J Radiat Oncol Biol Phys, 2006, 66 (5): 1399-407.
    [15]
    Wang J, Wang P, Pang QS, et al. Clinical and dosimetric factors associated with radiation-induced lung damage in patients with non small cell lung cancer treated with three-dimentional conformal radiotherapy[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 2009, 18(6): 448-51. [王静, 王平, 庞青松, 等. 非小细胞 肺癌三维适形放疗放射性肺损伤临床及剂量学因素分析[J]. 中 华放射肿瘤学杂志, 2009, 18(6): 448-51. ]
    [16]
    Wang J, Zhang TT, He ZC, et al. Severe acute radiation pneumonitis after concurrent chemoradiotherapy in non-small cell lung cancer[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 2012, 21 (4): 326-9. [王谨, 庄婷婷, 何智纯, 等. 非小细胞肺癌同期放 化疗后重度急性放射性肺炎的预测因素[J]. 中华放射肿瘤学杂 志, 2012, 21(4): 326-9.]
    [17]
    Wang D, Li B, Wang Z, et al. Functional dose-volume histograms for predicting radiation pneumonitis in locally advanced nonsmall cell lung cancer treated with late-course accelerated hyperfractionated radiotherapy[J]. Exp Ther Med, 2011, 2(5): 10 17-22.
    [18]
    Zhang XJ, Sun JG, Sun J, et al. Prediction of radiation pneumon itis in lung cancer patients: a systematic review[J]. J Cancer Res Clin Oncol, 2012, 138(12): 2103-16.
    [19]
    Dang J, Li G, Lu X, et al. Analysis of related factors associated with radiation pneumonitis in patients with locally advanced nonsmall- cell lung cancer treated with three-dimensional conformal radiotherapy[J]. J Cancer Res Clin Oncol, 2010, 136(8): 1169-78.
    [20]
    Kong FM, Hayman JA, Griffith KA, et al. Final toxicity results of a radiation-dose escalation study in patients with non-smallcell lung cancer (NSCLC): predictors for radiation pneumonitis a nd fibrosis[J]. Int J Radiat Oncol Biol Phys, 2006, 65(4): 1075-86.
    [21]
    Dang J, Li G, Ma L, et al. Predictors of grade ≥ 2 and grade ≥ 3 radiation pneumonitis in patients with locally advanced nonsmall cell lung cancer treated with three-dimensional conformal radiotherapy [J]. Acta Oncol, 2013, 52(6): 1175-80.
    [22]
    Parashar B, Edwards A, Mehta R, et al. Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer[J]. Am J Clin Oncol, 20 11, 34(2): 160-4.
    [23]
    Bradley JD, Paulus R, Komaki R, et al. A randomized phase Ⅲ comparison of standard-dose(60Gy)versus highdose( 74 Gy)comformal chemoradio+/- cetuximab for stage III nonsmall cell lung cancer: results on radiation dose in RTOG 0617[J]. J Clin Oncol, 2013, 31(suppl;abstr 7501).
  • Related Articles

    [1]XU Yao, LIU Shiguo, ZHANG Chang, ZHANG Li, JIANG Shan, ZHANG Junxia, PENG Li. Clinical Significance of Detection of ZIC1 Promoter Methylation in Peripheral Blood and Cancer Tissues of Non-small Cell Lung Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2021, 48(4): 354-357. DOI: 10.3971/j.issn.1000-8578.2021.20.0911
    [2]WAN Lihui, ZHANG Na, HUANG Ying, LI Wei, WANG Liuhua, ZHENG Yuqin, SUN Zhenzhu, CAO Yuwen. Clinical Significance of JAG1 Gene Methylation in Uygur Breast Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2017, 44(11): 734-739. DOI: 10.3971/j.issn.1000-8578.2017.17.0501
    [3]KANG Yani, LAI Dengpan, ZHANG Xiaoli, CHEN Jian, ZHAO Xiaodong. CpG Islands Methylation Status in SHP1 Gene Promoter Region in Gastric Cancer Cells[J]. Cancer Research on Prevention and Treatment, 2014, 41(08): 871-875. DOI: 10.3971/j.issn.1000-8578.2014.08.003
    [4]SONG Chao, ZHANG Yun, JIN Yongtang, YU Zaicheng, XUE Shaoli. Detection and Clinical Significance of DAPK Gene Methylation in Plasma of Non-small Cell Lung Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2013, 40(08): 772-775. DOI: 10.3971/j.issn.1000-8578.2013.08.011
    [5]GUO Wei, GUO Yan-li, YANG Zhi-bin, KUANG Gang, QIAO Yi-ling, DONG Zhi-ming. Promoter Methylation of Transforming Growth Factor-beta Receptor Type 1 Gene and Expression of TGF-β1 in Gastric Cardia Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2011, 38(05): 524-527. DOI: 10.3971/j.issn.1000-8578.2011.05.011
    [6]TAN Shuang-xiang, HU Rui-cheng, XIAO Zhi-qiang, TANG Can-e, YI Hong, RUAN Lin, WANG Ning, HONG Xiu-qin. Methylation of annexin A1 Gene Promotes Lymphoid Node Metastasis in Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2010, 37(12): 1374-1379. DOI: 10.3971/j.issn.1000-8578.2010.12.011
    [7]GUO Yan-li, JIN Guo-liang, GUO Wei, KUANG Gang, YANG Zhi-bin, DONG Zhi-ming. Relationship between Promoter Methylation of Wif-1 and Protein Expression of VEGF-C/VEGF-D in Gastric Cardia Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2010, 37(09): 1044-1047. DOI: 10.3971/j.issn.1000-8578.2010.09.018
    [8]DONG Zhi-ming, GUO Wei, HE Ming, YANG Zhi-bin, KUANG Gang, WANG Shi-jie. Expression and Methylation Status of RASSF1A Gene in Gastric Cardiac Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2009, 36(07): 566-570. DOI: 10.3971/j.issn.1000-8578.2009.07.008
    [9]YU Zong-tao, YUAN Ya-li, ZHANG Ji-cai, GAO Qiong, WANG Yuan-yuan. Transcriptional Expression and Promoter methylation of FHIT gene in Lung Carcinoma Tissues and Cell[J]. Cancer Research on Prevention and Treatment, 2007, 34(07): 498-500. DOI: 10.3971/j.issn.1000-8578.2226
    [10]LIU Fen, YU Jie-ping, DENG Quan-jun, QI Yuan-ling, YU Hong-gang. Studying the Expression of PTEN and Its CpG Island Methylation Status in Gastric Carcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2006, 33(09): 632-634. DOI: 10.3971/j.issn.1000-8578.1326

Catalog

    Article views (1448) PDF downloads (13478) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return